- Home
- SD vs ANGO Comparison
SD vs ANGO Comparison
Compare SD & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SD | ANGO |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.0M | 420.2M |
| IPO Year | 2006 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SD | ANGO |
|---|---|---|
| Price | $12.63 | $11.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.75 |
| AVG Volume (30 Days) | 315.1K | ★ 997.3K |
| Earning Date | 11-04-2026 | 10-08-2026 |
| Dividend Yield | ★ 4.12% | N/A |
| EPS Growth | ★ 12.43 | N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $25.99 | $5.47 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | $10.33 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $12.45 | $9.39 |
| 52 Week High | $18.45 | $16.29 |
Technical Indicators
Market Signals| Indicator | SD | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 27.89 | 38.99 |
| Support Level | N/A | $11.60 |
| Resistance Level | $14.45 | $12.50 |
| Average True Range (ATR) | 0.49 | 0.51 |
| MACD | -0.23 | 0.11 |
| Stochastic Oscillator | 3.56 | 18.11 |
Price Performance
Historical ComparisonAbout SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.